Cumberland Pharmaceuticals (CPIX) Reports Q4 EPS of $0.10

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q4 EPS of $0.10, versus ($0.10) reported last year. Revenue for the quarter came in at $9.3 million, versus $8.05 million reported last year.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
• Marvell Technology (MRVL) Tops Q2 EPS by 1c, Offers Guidance
• Affirm Holdings (AFRM) Tops Q4 EPS by $3.77, Beats on Revenue